Cargando…
Replication-inducible vaccinia virus vectors with enhanced safety in vivo
Vaccinia virus (VACV) has been used extensively as the vaccine against smallpox and as a viral vector for the development of recombinant vaccines and cancer therapies. Replication-competent, non-attenuated VACVs induce strong, long-lived humoral and cell-mediated immune responses and can be effectiv...
Autores principales: | O’Connell, Caitlin M., Jasperse, Brittany, Hagen, Caitlin J., Titong, Allison, Verardi, Paulo H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7117657/ https://www.ncbi.nlm.nih.gov/pubmed/32240193 http://dx.doi.org/10.1371/journal.pone.0230711 |
Ejemplares similares
-
Single dose of a replication-defective vaccinia virus expressing Zika virus-like particles is protective in mice
por: Jasperse, Brittany, et al.
Publicado: (2021) -
EPPIC (Efficient Purification by Parental Inducer Constraint) Platform for Rapid Generation of Recombinant Vaccinia Viruses
por: Jasperse, Brittany, et al.
Publicado: (2020) -
A vaccinia virus renaissance: New vaccine and immunotherapeutic uses after smallpox eradication
por: Verardi, Paulo H., et al.
Publicado: (2012) -
Broad Protection of Pigs against Heterologous PRRSV Strains by a GP5-Mosaic DNA Vaccine Prime/GP5-Mosaic rVaccinia (VACV) Vaccine Boost
por: Cui, Junru, et al.
Publicado: (2020) -
Tachypleus tridentatus Lectin Enhances Oncolytic Vaccinia Virus Replication to Suppress In Vivo Hepatocellular Carcinoma Growth
por: Li, Gongchu, et al.
Publicado: (2018)